Assisted Reproductive Techniques (ART) With Sperm Donation : an Inclusive Model of ART for All Women
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Nov 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the experiences of women who are seeking help to become parents using sperm donation. It aims to understand the different groups of women who request these services, whether they are single or in a same-sex relationship, and how their needs and support processes might differ. By examining the time it takes to receive care and the support provided at the hospital, researchers hope to improve the services offered to all women looking to start a family.
To be eligible for this study, participants must be women aged 29 to 74 who have sought help from the reproductive medicine department at a hospital in Nancy between January 2021 and June 2023. Unfortunately, minors and individuals under guardianship cannot participate. If you choose to take part, you will be helping researchers learn more about the needs of women in similar situations, which could lead to better support and resources in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • single women consulting the Reproductive Medicine Service for a parenthood project by sperm donation between January 2021 and June 2023.
- • women in relationship with women consulting the Reproductive Medicine Service for a parenthood project by sperm donation between January 2021 and June 2023
- Exclusion Criteria:
- • Minors
- • Person under guardianship
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nancy, , France
Patients applied
Trial Officials
AGOPIANTZ Mikael, PhD
Principal Investigator
Central HNF Nancy Regional University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported